| ||||||||||||||||||||||||
Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer Files in this Data Supplement:
Ann Oncol Younis et al.
18: 293
Supplementary Material
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer Files in this Data Supplement:
Ann Oncol Younis et al.
18: 293
Supplementary Material
| ||||||||||||||||||||||||